Updated results from inMMyCAR, the ongoing first-in-human phase 1 study of KLN-1010 in patients (pts) with relapsed and refractory multiple myeloma (RRMM).
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性,不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1200/jco.2026.44.16_suppl.7509
文献链接: https://ascopubs.org/doi/10.1200/JCO.2026.44.16_suppl.7509
其他信息:
出版社: American Society of Clinical Oncology (ASCO)
作者: P. Joy Ho; Andrew Spencer; Sueh-li Lim; Stephanie Talam; Hannah Pahl; Dharmesh Dingar; Scott Currence; Travis Quigley; Simon J. Harrison

